ESTUTC-5 New YorkLog in Sign up

ACHV
Achieve Life Sciences, Inc.
stockNASDAQ

At CloseNov 9, 2026 3:59:56 PM EST

6.79USD+1.042%(+0.07)1,089,178

Pre-marketNov 9, 2026 9:21:30 AM EST

6.95USD+3.423%(+0.23)

After-hoursNov 9, 2026 4:25:30 PM EST

6.75USD-0.589%(-0.04)

ACHV News

Day breaks

09:37 AM ESTAchieve Life Sciences reports Q3 results ·

Seeking Alpha

08:00 AM ESTAchieveRx Reports Third Quarter 2026 Financial Results and Provides Business Updates ·

GlobeNewswire Inc.

08:12 AM ESTAchieve Life Sciences rebrands as AchieveRx, changes ticker to QUIT ·

Investing.com

08:30 AM ESTAchieve Life Sciences Announces Granting of New Hire Inducement Awards ·

GlobeNewswire Inc.

08:26 AM EDTH.C. Wainwright reiterates Achieve Life Sciences stock rating on trial data ·

Investing.com

08:30 AM EDTAchieve Life Sciences Presents 52-Week Cytisinicline Results for Smoking and Vaping Cessation at CHEST 2026 ·

GlobeNewswire Inc.

08:30 AM EDTAchieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications ·

GlobeNewswire Inc.

04:02 PM EDTAchieve Life Sciences Announces Granting of New Hire Inducement Awards ·

GlobeNewswire Inc.

08:44 AM EDTAchieve Life Sciences names Benjamin Halladay as CFO ·

Investing.com

08:39 AM EDTAchieve Life Sciences appoints Benjamin Halladay as CFO ·

Seeking Alpha+1 source

08:30 AM EDTAchieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer ·

GlobeNewswire Inc.+1 source

11:39 AM EDTAchieve a new Buy at Stifel on potential of smoking cessation drug cytisinicline ·

Seeking Alpha

08:23 AM EDTUS Futures, Treasuries Flat Ahead Of Core PCE, Micron Earnings ·

Zero Hedge

05:01 PM EDTStifel initiates Achieve Life Sciences stock with buy rating ·

Investing.com

08:30 AM EDTAchieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026 ·

GlobeNewswire Inc.